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CREB has been reported to be activated by injury and is commonly used as marker for pain-related plasticity
changes in somatosensory pathways, including spinal dorsal horn neurons and the anterior cingulate cortex (ACC).
However no evidence has been reported to support the direct role of activated CREB in injury-related behavioral
sensitization (or allodynia). Here we report that genetic enhancement of CREB-mediated transcription selectively in
forebrain areas enhanced behavioral responses to non-noxious stimuli after chronic inflammation (CFA model) or
nerve injury. In contrast, behavioral acute responses to peripheral subcutaneous injection of formalin did not show
any significant difference. Furthermore, acute pain responses to noxious thermal stimuli were also not affected. Our
results thus provide direct evidence that cortical CREB-mediated transcription contributes to behavioral allodynia in
animal models of chronic inflammatory or neuropathic pain.Background
Activity-dependent gene expression is important for long
term changes in synaptic transmission [1,2]. Increases in
intracellular Ca2+ concentrations activate various intra-
cellular signaling cascades, including cAMP and Ca2+
calmodulin (CaM) dependent protein kinase pathways
[3]. These pathways in turn lead to the phosphorylation
of the transcription factor cAMP responsive element
binding protein (CREB) at the serine 133 site [4]. CREB
is a major transcription factor that plays a central role in
the formation of long-term memory [5-10]. Accordingly,
genetic enhancement of forebrain CREB corresponds
with enhancements in long term memory and late-phase
long term potentiation (L-LTP) in the CA1 region of the
hippocampus [11]; whereas genetic inhibition of CREB
in the nucleus accumbens increases the rewarding effi-
cacy of cocaine [12].
Peripheral injury triggers long term potentiation of
transmission in cortical ACC synapses [13-15]. Although* Correspondence: min.zhuo@utoronto.ca
1Department of Physiology, Faculty of Medicine, University of Toronto, 1
King's College Circle; University of Toronto Center for the study of Pain,
Toronto, Ontario M5S 1A8, Canada
2Center for Neuron and Disease, Frontier Institute of Science and
Technology, Xi’an Jiaotong University, 28 Xianning West Road, Xian, Shaanxi
710049, China
Full list of author information is available at the end of the article
© 2012 Descalzi et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orinjury-induced activation of CREB (phosphorylation) in
cortical areas has been reported [7], no study has shown
direct evidence that CREB-mediated transcription in the
cortex actually contributes to behavioral sensitization.
To address this question, we used transgenic mice
expressing dominant active CREB mutant in the fore-
brain (Y134F) driven by the αCaMKII promoter [11],
which is expressed predominantly in forebrain regions,
including cirtical areas, amygdala, and hippocampus
[16]. These mice show increased CREB activity to sen-
sory stimuli, and exhibit enhancements in long term
memory and L-LTP in the CA1 region of the hippocam-
pus [11]. In this short report, we present evidence that
enhanced CREB activity in the forebrain leads to the en-
hancement of behavioral responses to non-noxious stim-
uli after injury.
In order to determine if forebrain overexpression
could affect acute nociception, we first exposed both
groups of mice to the hot plate (55°C) and tail flick tests
of thermal nociception. Both groups of mice showed
similar response latencies to the hot plate (WT: 7 ±
1 sec, n = 7; Y134F: 8 ± 1 sec, n = 7; Figure 1A) and tail
flick tests (WT: 6 ± 1 sec, n = 7; Y134F: 6 ± 1 sec, n = 7;
Figure 1B). Acute pain is physiological, with an obvious
advantageous survival purpose. This form of pain isl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 (See legend on next page.)
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Figure 1 Behavioral assessment of acute, inflammatory, and neuropathic pain. A) Acute nociception was unaltered by forebrain CREB
overexpression. Response latencies in the hot plate and B) tail flick tests were similar between groups. C) 50% mechanical threshold levels were
indistinguishable between groups. D) Formalin test, Y134F mice show significantly less licking responses than WT mice (F(1, 22) = 12.68, P = 0.004).
E) A significant interaction was detected, whereby Y134F mice only showed decreases in Phase 2 (10 – 60 min) and 3 (60 – 120 min), but not
Phase 1 (0 – 10 min) of the formalin test. Phase 1 corresponds with acute inflammatory pain, whereas Phase 2 and 3 represent more tonic states
of pain. F) In the CFA model of chronic inflammatory pain, Y134F mice showed a significant enhancement in CFA induced mechanical allodynia
up to 1 Week post CFA application (F(1, 18) = 21.67, P = 0.003). G) Enhanced allodynia was also seen in the uninjected paw. H) In the neuropathic
pain model, Y134F mice showed a significant enhancement in mechanical allodynia up to 2 weeks post surgery (F(1, 24) = 43.61, P < 0.001).
I) Neuropathic pain also produced a significant enhancement in the uninjected paw at 2 weeks.
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Ca2+ calmodulin dependent intracellular pathways
[7,17]. Accordingly, both groups of mice also showed
similar 50% mechanical response thresholds (WT: 0.7 ±
0.1 g, n = 7; Y134F: 0.7 ± 0.1 g, n = 7; Figure 1C). These
results indicate that CREB overexpression in the fore-
brain does not alter basal nociceptive thresholds.
We next sought to determine the effects of forebrain
CREB overexpression on acute inflammatory pain by
measuring behavioral (licking) responses to inflamma-
tion brought on by intradermal injections of formalin
(5%) to the hindpaw [18]. Transgenic mice with fore-
brain NMDA receptor subtype NR2B overexpression
show a robust enhancement of acute inflammatory pain
[18]; whereas transgenic mice with a genetic deletion of
adenylyl cyclase type 1 (AC1) show reduced behavioral
nociceptive responses to peripheral injection of formalin
[17,19]. Within the first 10 min after formalin injection,
behavioral responses were undistinguishable between
WT and Y134F mice (Figure 1D). In the subsequent
phases of the test, however, Y134F mice showed a
marked reduction in responses, which lasted well into
2 hrs post injection. Indeed, a repeated measures two-
way ANOVA revealed a significant main difference in
licking time between WT and Y134F mice, and showed
a significant interaction between group and time,
whereby Y134F mice showed significantly less licking be-
havior only during phases 2 and 3, but not 1 (Phase 1:
WT: 59 ± 20 sec, n = 6; Y134F 45 ± 10 sec, n = 7; P =
0.8; Phase 2: WT: 454 ± 71 sec, n = 6; Y134F 288 ±
34 sec, n = 7; P < 0.001; Phase 3: WT: 339 ± 68 sec, n =
6; Y134F 141 ± 34 sec, n = 7; P < 0.001; Figure 1E). The
lack of difference during phase one is consistent with
the observation that acute behavioral responses to nox-
ious stimuli were not affected in the same mice. In the
later stages of the test however (Phase 2 and 3), we saw
a marked reduction in licking behavior. These results
however differ from previous reports in mice with NR2B
forebrain overexpression, indicating that genetic ma-
nipulation at downstream signaling targets may cause
different phenotypes [18]. Future studies are needed to
investigate the exact mechanism. This finding also raises
the possibility that cortical CREB activity may notdirectly contribute to behavioral responses in cases of
acute inflammation.
Next, we assessed mechanical sensitization in a
chronic inflammatory pain model using complete
Freund’s adjuvant (CFA) injected into the hind paw. We
measured mechanical allodynia in mice by quantifying
paw withdrawal behavior in response to applications of
an innocuous mechanical stimulus, which under normal
conditions (baseline) yields very few responses [18].
Y134F mice showed robust enhancements of mechanical
allodynia (Figure 1F), which was apparent at 24 h (WT:
56 ± 8%, n = 4; Y134F 88 ± 5%, n = 4; P = 0.007), 3 days
(WT: 25 ± 8%, n = 4; Y134F 54 ± 13%, n = 4; P = 0.01),
and 1 week after CFA injection (WT: 18 ± 7%, n = 4;
Y134F 46 ± 9%, n = 4; P = 0.01). In the contralateral
paw, differences were only detected at 3 days post injec-
tion (WT: 13 ± 4%, n = 4; Y134F 38 ± 11%, n = 4; P =
0.01; Figure 1G).
Nerve injury (neuropathic pain model) activates Ca2+
calmodulin dependent pathways within the anterior cin-
gulate cortex (ACC) [7,19], a forebrain structure
involved in the affective component of pain [20,21]. We
next compared behavioral responses in WT and CREB-
Y134F mice after exposing both groups to ligation of the
common peroneal nerve, which induces robust chronic
pain in mice lasting weeks [22]. Although no differences
could be detected at baseline, a repeated measures two-
way ANOVA revealed a significant difference of mech-
anical allodynia between groups (Figure 1H). Post-hoc
analyses further showed that Y134F mice present a
significant enhancement in mechanical allodynia at 1
and 2 weeks after nerve ligation surgery (1 week: WT:
54 ± 7%, n = 7; Y134F 82 ± 8%, n = 7; P < 0.001),
(2 weeks: WT: 42 ± 7%, n = 6; Y134F 75 ± 11%, n = 7;
P < 0.001). Interestingly, Y134F mice also showed
enhanced allodynia in the contralateral (non-injured)
hindpaw, which remained significantly higher after
2 weeks (1 week: WT: 34 ± 5%, n = 7; Y134F 54 ± 11%,
n = 7; P = 0.3) (2 weeks: WT: 10 ± 7%, n = 6; Y134F 41 ±
10%, n = 7; P = 0.005; Figure 1I).
In conclusion, we report here for the first time, to our
knowledge, that enhancement of CREB activity within
forebrain neurons potentiates behavioral responses to
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tory pain and neuropathic pain. This is supported by
previous reports that synaptic potentiation (or called
LTP) is enhanced in the regions of the hippocampus
[11] and the ACC (Chen et al., unpublished data). In
contrast, observations that basal excitatory synaptic
transmission is not affected in the same transgenic mice
supports our current findings that acute responses to
physiological noxious thermal and mechanical stimuli
were unaffected. Accordingly, forebrain CREB overex-
pression does not affect the first phase of the formalin
test, during which behavioral responses represent direct
activation of nociceptive pathways. In contrast, reduc-
tion of responses were observed in the later phases (2
and 3), which are thought to be mediated by mechan-
isms involved in central sensitization of nociceptive
transmission [23]. These reductions were surprising, and
caution should therefore be exercised before using CREB
as a marker for acute inflammatory pain. For example,
previous observations in the spinal cord have shown
formalin-induced CREB phosphorylation in ipsilateral
and contralateral dorsal root ganglion (DRG) neurons
that reached peak expression at 10 min [23], whereas be-
havioral responses to formalin injections last beyond
1 hr.
Chronic pain produced through peripheral inflamma-
tion or nerve injury corresponds with potentiation of ex-
citatory transmission in ACC synapses [13,14,24], which
is partly induced through increases in postsynaptic
AMPA receptor GluA1 subunits [13]. Gene expression is
important for long term changes in synaptic transmis-
sion [1,2], and CREB has been implicated in various
events that are known to correspond with changes in
postsynaptic receptors including fear learning [8,9,11]
and drug addiction [25]. Chronic pain requires the acti-
vation of cAMP and Ca2+ -CaM dependent protein kin-
ase pathways, and the disruption of these pathways
reduces chronic pain [7,26]. As chronic pain [13] and
fear learning [27] have been shown to correspond with
increases in postsynaptic AMPA GluA1 receptors within
the ACC, it is likely that CREB is involved in the pain
induced, Ca2+ CaM dependent, upregulation of postsy-
naptic AMPA GluA1 receptors, and thus contributes to
enhancements in excitatory synaptic transmission within
the ACC. The ACC receives robust projections from the
thalamus and in turn also projects to thalamic and spinal
pathways [28,29]. Forebrain overexpression of CREB can
thus facilitate increases in excitatory transmission within
the ACC, and enhance top-down descending facilitation
of spinal sensory transmission [30-32]. It is important to
note however, that as the mice used in this study express
the dominant active CREB mutant transgene in a num-
ber of forebrain structures, other forebrain areas may
also be involved, such as the insular cortex, amygdala,and hippocampus. Future studies are needed to investi-
gate experience-induced synaptic and structural changes
in the transgenic mice.
Methods
Animals
Adult (8–12 month) transgenic mice Y134F line C,
expressing dominant active CREB in the forebrain, and
age matched WT littermates were used for all studies as
reported previously [11]. Genotypes were identified by
PCR analysis of genomic DNA extracted from mouse
ear tissue. All mice were housed under a 12 h light/dark
cycle with food and water provided ad libitum. All
mouse protocols are in accordance with National Insti-
tutes of Health guidelines and approved by the Animal
Care and Use Committee of University of Toronto.Behavioral experiments
Acute pain assessment was performed as published pre-
viously [18]. Briefly, we determined the latency of behav-
ioral responses to placement on a thermal hot plate (55°C)
(Columbus Instruments, Columbus, OH), and the latency
for the spinal nociceptive tail-flick reflex, evoked by radi-
ant heat applied to the underside of the tail (Columbus
Instruments, Columbus, OH). All tests were performed
blind to genotype. Fifty percent mechanical threshold was
assessed with a set of von Frey filaments (Stoelting, Wood
Dale, Illinois) using the up-and-down method [33]. Briefly,
mice were placed in plexiglass containers with elevated
wire mesh flooring, and were allowed to acclimate for
30 min before testing. A threshold stimulus was deter-
mined by observing animal hind paw withdrawal upon
application of a von Frey filament; positive responses
included prolonged hind paw withdrawal, or licking or bit-
ing of the hind paw. Mechanical allodynia was measured
as described previously [18], and was assessed with the 0.4
mN (No. 2.44) von Frey filament, previously observed to
produce minimal hind paw withdrawal in untreated mice
[18]. Positive responses included licking, biting, and pro-
longed withdrawal of the hindpaw. Experiments consisted
of 10 trials, with 10 min inter-trial intervals. All observa-
tions were performed blind.Inflammatory pain models
Formalin (5%, 10 μl; Sigma-Aldrich) or complete
Freund’s adjuvant (CFA, 50%, 10 μl; Sigma-Aldrich) was
injected subcutaneously into the dorsal side of the left
hind paw as reported previously [18]. In the formalin
test, the total time spent licking or biting the injected
hind paw was recorded for each five-minute intervals for
two hours post injection. In the CFA model, mechanical
sensitivity was assessed.
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The neuropathic pain model consisted of ligation of the
common peroneal nerve (CPN) and was performed as
previously described [13,22]. Briefly, mice were anesthe-
tized by inhaled isofluorane (1-3%). A 1 cm skin incision,
from the fibular head to the lateral side of the ankle
joint, was made, followed by an incision of the subcuta-
neous tissue. A vertical incision was made of the white
fascia, and the posterior muscles were pulled laterally to
expose the CPN, which was ligated with 5–0 chromic
gut sutures (Ethicon). Skin was sutured with sterile
5–0 silk.
Data analysis
Results were expressed as mean ± s.e.m. Unpaired stu-
dent t-tests and two-way repeated Analyses of Variance
(ANOVA) were performed, with the Holme-Sidak test
for multiple comparisons performed post-hoc if signifi-
cant differences were observed. In all cases P < 0.05 was
considered statistically significant.
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